Gemechu Shimelis Dejene, van Vliet Christine M, Win Aung Ko, Figueiredo Jane C, Le Marchand Loic, Gallinger Steven, Newcomb Polly A, Hopper John L, Lindor Noralane M, Jenkins Mark A, Dowty James G
Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC, Australia.
Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, VIC, Australia.
Fam Cancer. 2020 Jul;19(3):215-222. doi: 10.1007/s10689-020-00167-4. Epub 2020 Feb 27.
Individuals who carry pathogenic mutations in DNA mismatch repair (MMR) genes have high risks of cancer, and small studies have suggested that these risks depend on the sex of the parent from whom the mutation was inherited. We have conducted the first large study of such a parent-of-origin effect (POE). Our study was based on all MMR gene mutation carriers and their relatives in the Colon Cancer Family Registry, comprising 18,226 people. The POE was estimated as a hazard ratio (HR) using a segregation analysis approach that adjusted for ascertainment. HR = 1 corresponds to no POE and HR > 1 corresponds to higher risks for maternal mutations. For all MMR genes combined, the estimated POE HRs were 1.02 (95% confidence interval (CI) 0.75-1.39, p = 0.9) for male colorectal cancer, 1.12 (95% CI 0.81-1.54, p = 0.5) for female colorectal cancer and 0.84 (95% CI 0.52-1.36, p = 0.5) for endometrial cancer. Separate results for each MMR gene were similar. Therefore, despite being well-powered, our study did not find any evidence that cancer risks for MMR gene mutation carriers depend on the parent-of-origin of the mutation. Based on current evidence, we do not recommend that POEs be incorporated into the clinical guidelines or advice for such carriers.
携带DNA错配修复(MMR)基因致病性突变的个体患癌风险很高,一些小型研究表明,这些风险取决于突变所遗传的亲本的性别。我们开展了首例关于这种起源亲本效应(POE)的大型研究。我们的研究基于结肠癌家族登记处的所有MMR基因突变携带者及其亲属,共18226人。采用经确诊调整的分离分析方法,将POE估计为风险比(HR)。HR = 1表示无POE,HR > 1表示母系突变风险更高。对于所有合并的MMR基因,男性结直肠癌的估计POE HR为1.02(95%置信区间(CI)0.75 - 1.39,p = 0.9),女性结直肠癌为1.12(95% CI 0.81 - 1.54,p = 0.5),子宫内膜癌为0.84(95% CI 0.52 - 1.36,p = 0.5)。每个MMR基因的单独结果相似。因此,尽管我们的研究样本量充足,但未发现任何证据表明MMR基因突变携带者的癌症风险取决于突变的起源亲本。基于目前的证据,我们不建议将起源亲本效应纳入针对此类携带者的临床指南或建议中。